Research programme: stem cell therapies - Angiocrine Bioscience
Latest Information Update: 26 Aug 2014
At a glance
- Originator Angiocrine Bioscience
- Developer Angiocrine Bioscience; Weill Cornell Medical College
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Unspecified